Publications
Understanding tumor lysis syndrome
Endothelium, Inflammation & Allogenicity, Intensive Care Med. Nov 30, 2019
CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker
Onco-dermatology and therapies, Cancers Nov 16, 2019
CD8+PD-1-ILT2+ T Cells Are an Intratumoral Cytotoxic Population Selectively Inhibited by the Immune-Checkpoint HLA-G
HLA-G immune checkpoint in Oncology and Transplantation, Cancer Immunol Res. Oct 30, 2019
The multifaceted immune regulation of bladder cancer
Immune responses in the immunocompromised host, Nature Rev. Urol Oct 30, 2019
Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial
Endothelium, Inflammation & Allogenicity, Am. J. Transplant Oct 30, 2019
Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after decea- sed-donor kidney transplantation in patients with preformed donor-specific antibodies
Endothelium, Inflammation & Allogenicity, Am. J. Transplant Oct 30, 2019
A Quantitative Multivariate Model of Human Dendritic Cell-T Helper Cell Communication
Human Systems Immunology & Inflammatory Networks, Cell Oct 3, 2019
HLA-DQ alloantibodies directly activate the endothelium and compromise dif- ferentiation of FoxP3high regulatory T lymphocytes
Endothelium, Inflammation & Allogenicity, Kidney Int. Sep 30, 2019
Abolishing serum interference in detection of HLA antibodies: Who, How, When and Why?
Endothelium, Inflammation & Allogenicity, Human Immunol. Sep 30, 2019
Extracellular Vesicles Released by Allogeneic Human Cardiac Stem/Progenitor Cells as Part of their Therapeutic Benefit
Skin immunity and inflammation, Stem Cells Translational Med. Sep 30, 2019